47. DETECTION OF BACTEROIDES FRAGILIS BACTERIA IN TUMORS OF COLORECTAL CANCER PATIENTS
Main Article Content
Abstract
Objective: To investigate the presence of Enterotoxigenic Bacteroides fragilis (ETBF) in colorectal cancer (CRC) patients in Vietnam.
Methods: A cross-sectional descriptive study was conducted using molecular biology techniques and a convenience sampling method. The study included 123 patients diagnosed with colorectal cancer in 2023–2024 at Military Hospital 175, Vietnam.
Results: Using a range of recombinant plasmid concentrations from 106 to 1 copy alongside DNA extracted from healthy human blood samples, the PCR method demonstrated detection sensitivity down to 10 bacterial copies per clinical sample. Optimized PCR conditions were applied to the 123 CRC samples, identifying B. fragilis in 82 samples, corresponding to a positivity rate of 66.7%. No correlation was observed between the presence of B. fragilis and patient characteristics such as age, sex, tumor differentiation, tumor location, or invasion depth.
Conclusion: The positivity rate for Enterotoxigenic Bacteroides fragilis among CRC patients in Vietnam is relatively high. These findings suggest that microbiota alterations could have potential as a biomarker for early detection of colorectal cancer.
Article Details
Keywords
Enterotoxigenic Bacteroides fragilis, CRC, PCR
References
[2] N. Ulger Toprak, A. Yagci, B.M. Gulluoglu, M.L. Akin, P. Demirkalem, T. Celenk, G. Soyletir, A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer, Clin. Microbiol. Infect. 12 (2006) 782–786. https://doi.org/10.1111/j.1469-0691.2006.01494.x.
[3] X. Wang, Y. Yang, D.R. Moore, S.L. Nimmo, S.A. Lightfoot, M.M. Huycke, 4-Hydroxy-2-Nonenal Mediates Genotoxicity and Bystander Effects Caused By Enterococcus Faecalis-Infected Macrophages, Gastroenterology. 142 (2012) 543-551.e7. https://doi.org/10.1053/j.gastro.2011.11.020.
[4] Y. Zhou, H. He, H. Xu, Y. Li, Z. Li, Y. Du, J. He, Y. Zhou, H. Wang, Y. Nie, Association of oncogenic bacteria with colorectal cancer in South China, Oncotarget. 7 (2016) 80794–80802. https://doi.org/10.18632/oncotarget.13094.
[5] A. Shariati, S. Razavi, E. Ghaznavi-Rad, B. Jahanbin, A. Akbari, S. Norzaee, D. Darban-Sarokhalil, Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study, Infect. Agent. Cancer. 16 (2021) 1–10. https://doi.org/10.1186/s13027-021-00381-4.
[6] W.T. Cheng, H.K. Kantilal, F. Davamani, The mechanism of bacteroides fragilis toxin contributes to colon cancer formation, Malaysian J. Med. Sci. 27 (2020) 9–21. https://doi.org/10.21315/mjms2020.27.4.2.
[7] J.E. Joo, Y.L. Chu, P. Georgeson, R. Walker, K. Mahmood, M. Clendenning, A.L. Meyers, J. Como, S. Joseland, S.G. Preston, N. Diepenhorst, J. Toner, D.J. Ingle, N.L. Sherry, A. Metz, B.M. Lynch, R.L. Milne, M.C. Southey, J.L. Hopper, A.K. Win, F.A. Macrae, I.M. Winship, C. Rosty, M.A. Jenkins, D.D. Buchanan, Intratumoral presence of the genotoxic gut bacteria pks + E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer, Br. J. Cancer. 130 (2024) 728–740. https://doi.org/10.1038/s41416-023-02554-x.
[8] E. Morgan, M. Arnold, A. Gini, V. Lorenzoni, C.J. Cabasag, M. Laversanne, J. Vignat, J. Ferlay, N. Murphy, F. Bray, Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN, Gut. 72 (2023) 338–344. https://doi.org/10.1136/GUTJNL-2022-327736.
[9] N.D. Truong, Bacteroides fragilis infection may be associated with colorectal cancer, J. 108 - Clin. Med. Phamarcy. 18 (2023). https://doi.org/10.52389/ydls.v18i7.2060.
[10] R. V. Purcell, J. Pearson, A. Aitchison, L. Dixon, F.A. Frizelle, J.I. Keenan, Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia, PLoS One. 12 (2017). https://doi.org/10.1371/journal.pone.0171602.